Pharmacokinetics and pharmacodynamics of six epoetin alfa dosing regimens in anemic critically ill patients without acute blood loss. (yeni pencere açar)

Arroliga AC, Guntupalli KK, Beaver JS, Langholff W, Marino K, Kelly K

Kaynak‎: Crit Care Med 2009;37(4):1299-307.

İndeks‎: PubMed 19242343

DOI‎: 10.1097/CCM.0b013e31819cec94

https://www.ncbi.nlm.nih.gov/pubmed/19242343 (yeni pencere açar)

Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses. (yeni pencere açar)

Ball AM, Winstead PS.

Kaynak‎: Pharmacotherapy 2008;28(11):1383-90.

İndeks‎: PubMed 18956998

DOI‎: 10.1592/phco.28.11.1383

https://www.ncbi.nlm.nih.gov/pubmed/18956998 (yeni pencere açar)

Reducing postburn injury anemia in a Jehovah's Witness patient. (yeni pencere açar)

Barsun A, Sen S, Palmieri TL, Greenhalgh DG

Kaynak‎: J Burn Care Res 2014;35(4):e258-61.

İndeks‎: PubMed 24121804

DOI‎: 10.1097/BCR.0b013e3182a366c5

https://www.ncbi.nlm.nih.gov/pubmed/24121804 (yeni pencere açar)

A US multicenter, retrospective, observational study of erythropoiesis-stimulating agent utilization in anemic, critically ill patients admitted to the intensive care unit. (yeni pencere açar)

Brophy GM, Sheehan V, Shapiro MJ, Lottenberg L, Scarlata D, Audhya P; ASSESS Study Group and Amgen Inc

Kaynak‎: Clin Ther 2008;30(12):2324-34.

İndeks‎: PubMed 19167591

DOI‎: 10.1016/j.clinthera.2008.12.024

https://www.ncbi.nlm.nih.gov/pubmed/19167591 (yeni pencere açar)

Severe acute anemia after liver transplantation in an elderly Jehovah's Witness treated with high-dose erythropoietin and ferric carboxymaltose: a case report. (yeni pencere açar)

Brunetta DM, Kaufman J, De Santis GC, Mesquita DF, Souza FN, Garcia JH.

Kaynak‎: Transplant Proc 2015;47(8):2548-51.

İndeks‎: PubMed 26518969

DOI‎: 10.1016/j.transproceed.2015.09.014

https://www.ncbi.nlm.nih.gov/pubmed/26518969 (yeni pencere açar)

Recombinant human erythropoietin in severe anaemia: issues of dosing and duration. (yeni pencere açar)

Charles A, Purtill M, Napolitano LM.

Kaynak‎: Anaesth Intensive Care 2006;34(6):793-6.

İndeks‎: PubMed 17183900

https://www.ncbi.nlm.nih.gov/pubmed/17183900 (yeni pencere açar)

Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial. (yeni pencere açar)

Corwin HL, Gettinger A, Rodriguez RM, Pearl RG, Gubler KD, Enny C, Colton T, Corwin MJ.

Kaynak‎: Crit Care Med 1999;27(11):2346-50.

İndeks‎: PubMed 10579246

https://www.ncbi.nlm.nih.gov/pubmed/10579246 (yeni pencere açar)

Erythropoietin for critically ill trauma patients: a missed opportunity? (yeni pencere açar)

Corwin HL, Napolitano LM

Kaynak‎: J Trauma Acute Care Surg 2014;77(5):774-9.

İndeks‎: PubMed 25494432

DOI‎: 10.1097/TA.0000000000000442

https://www.ncbi.nlm.nih.gov/pubmed/25494432 (yeni pencere açar)

Postoperative management of severe acute anemia in a Jehovah's Witness. (yeni pencere açar)

de Araújo Azi LM, Lopes FM, Garcia LV

Kaynak‎: Transfusion 2014;54(4):1153-7.

İndeks‎: PubMed 24117834

DOI‎: 10.1111/trf.12424

https://www.ncbi.nlm.nih.gov/pubmed/24117834 (yeni pencere açar)

Restrictive transfusion in geriatric trauma patients. (yeni pencere açar)

DeLeon AN, Uecker JM, Stafford SV, Ali S, Clark A, Brown CV

Kaynak‎: Am Surg 2016;82(1):85-8.

İndeks‎: PubMed 26802863

https://www.ncbi.nlm.nih.gov/pubmed/26802863 (yeni pencere açar)

High-dose recombinant human erythropoietin stimulates reticulocyte production in patients with multiple organ dysfunction syndrome. (yeni pencere açar)

Gabriel A, Kozek S, Chiari A, Fitzgerald R, Grabner C, Geissler K, Zimpfer M, Stockenhuber F, Bircher NG

Kaynak‎: J Trauma 1998;44(2):361-7.

İndeks‎: PubMed 9498512

DOI‎: 10.1097/00005373-199802000-00023

https://www.ncbi.nlm.nih.gov/pubmed/9498512 (yeni pencere açar)

Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317]. (yeni pencere açar)

Georgopoulos D, Matamis D, Routsi C, Michalopoulos A, Maggina N, Dimopoulos G, Zakynthinos E, Nakos G, Thomopoulos G, Mandragos K, Maniatis A; Critical Care Clinical Trials Greek Group.

Kaynak‎: Crit Care 2005;9(5):R508-15.

İndeks‎: PubMed 16277712

DOI‎: 10.1186/cc3786

https://www.ncbi.nlm.nih.gov/pubmed/16277712 (yeni pencere açar)

Management of a Jehovah's Witness patient with sepsis and profuse bleeding after emergency coronary artery bypass graft surgery: rethinking the critical threshold of oxygen delivery. (yeni pencere açar)

Hong T, Shander A, Agarwal S, Castresana M.

Kaynak‎: A A Case Rep 2015;4(10):127-31.

İndeks‎: PubMed 25974416

DOI‎: 10.1213/XAA.0000000000000144

https://www.ncbi.nlm.nih.gov/pubmed/25974416 (yeni pencere açar)

Management strategies for perioperative anaemia in the severely burn-injured Jehovah's Witness patients who decline a blood transfusion: a systematic review with illustrative case reports. (yeni pencere açar)

Jung M, Harish V, Wijewardena A, Kerridge I, Gillies R

Kaynak‎: Burns. 2023 49(3):716-29. Epub 2022 Jul 18.

İndeks‎: PubMed 35941026

DOI‎: 10.1016/j.burns.2022.07.002

https://pubmed.ncbi.nlm.nih.gov/35941026/ (yeni pencere açar)

Long-term ECMO treatment in Jehovah's Witness patient without transfusions. (yeni pencere açar)

Lindholm J, Palmér K, Frenckner B.

Kaynak‎: Perfusion 2012;27(4):332-4.

İndeks‎: PubMed 22496111

DOI‎: 10.1177/0267659112444328

https://www.ncbi.nlm.nih.gov/pubmed/22496111 (yeni pencere açar)

Outcomes with the use of recombinant human erythropoietin in critically ill burn patients. (yeni pencere açar)

Lundy JB, Hetz K, Chung KK, Renz EM, White CE, King BT, Huzar T, Wolf SE, Blackbourne LH

Kaynak‎: Am Surg 2010;76(9):951-6.

İndeks‎: PubMed 20836341

https://www.ncbi.nlm.nih.gov/pubmed/20836341 (yeni pencere açar)

Safety of off-label erythropoiesis stimulating agents in critically ill patients: a meta-analysis. (yeni pencere açar)

Mesgarpour B, Heidinger BH, Schwameis M, Kienbacher C, Walsh C, Schmitz S, Herkner H.

Kaynak‎: Intensive Care Med 2013;39(11):1896-908.

İndeks‎: PubMed 23928897

DOI‎: 10.1007/s00134-013-3030-9

https://www.ncbi.nlm.nih.gov/pubmed/23928897 (yeni pencere açar)

Transfusion-free treatment strategies for acute anemia in critical care. (yeni pencere açar)

Morgan CA, Byul Sarah S, Forest CP.

Kaynak‎: JAAPA 2016;29(8):38-44.

İndeks‎: PubMed 27467297

DOI‎: 10.1097/01.JAA.0000488695.96294.33

https://www.ncbi.nlm.nih.gov/pubmed/27467297 (yeni pencere açar)

Improved survival of critically ill trauma patients treated with recombinant human erythropoietin. (yeni pencere açar)

Napolitano LM, Fabian TC, Kelly KM, Bailey JA, Block EF, Langholff W, Enny C, Corwin HL.

Kaynak‎: J Trauma 2008;65(2):285-97.

İndeks‎: PubMed 18695463

DOI‎: 10.1097/TA.0b013e31817f2c6e

https://www.ncbi.nlm.nih.gov/pubmed/18695463 (yeni pencere açar)

Reticulocyte counts and their relation to hemoglobin levels in trauma patients. (yeni pencere açar)

Otterman ML, Nijboer JM, van der Horst IC, van Meurs M, ten Duis HJ, Nijsten MW

Kaynak‎: J Trauma 2009;67(1):121-4.

İndeks‎: PubMed 19590320

DOI‎: 10.1097/TA.0b013e318187a848

https://www.ncbi.nlm.nih.gov/pubmed/19590320 (yeni pencere açar)

Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. (yeni pencere açar)

Pieracci FM, Henderson P, Rodney JR, Holena DN, Genisca A, Ip I, Benkert S, Hydo LJ, Eachempati SR, Shou J, Barie PS.

Kaynak‎: Surg Infect (Larchmt) 2009;10(1):9-19.

İndeks‎: PubMed 19245362

DOI‎: 10.1089/sur.2008.043

https://www.ncbi.nlm.nih.gov/pubmed/19245362 (yeni pencere açar)

How do we treat life-threatening anemia in a Jehovah's Witness patient? (yeni pencere açar)

Posluszny JA Jr, Napolitano LM.

Kaynak‎: Transfusion 2014;54(12):3026-34.

İndeks‎: PubMed 25330835

DOI‎: 10.1111/trf.12888

https://www.ncbi.nlm.nih.gov/pubmed/25330835 (yeni pencere açar)

Recombinant human erythropoietin use in a critically ill Jehovah's Witness after cardiac surgery. (yeni pencere açar)

Price S, Pepper JR, Jaggar SI.

Kaynak‎: Anesth Analg 2005;101(2):325-7.

İndeks‎: PubMed 16037136

DOI‎: 10.1213/01.ANE.0000159158.70532.D0

https://www.ncbi.nlm.nih.gov/pubmed/16037136 (yeni pencere açar)

Successful rescue therapy for severe acute anemia: managing the critically ill Jehovah's Witness. (yeni pencere açar)

Rebel A, Beck A, Efron P, Bavry AA, Ang D.

Kaynak‎: Am Surg 2015;81(6):e263-5.

İndeks‎: PubMed 26031262

https://www.ncbi.nlm.nih.gov/pubmed/26031262 (yeni pencere açar)

Erythropoietin response is blunted in critically ill patients. (yeni pencere açar)

Rogiers P, Zhang H, Leeman M, Nagler J, Neels H, Mélot C, Vincent JL

Kaynak‎: Intensive Care Med 1997;23(2):159-62.

İndeks‎: PubMed 9069000

DOI‎: 10.1007/s001340050310

https://www.ncbi.nlm.nih.gov/pubmed/9069000 (yeni pencere açar)

Life-threatening postoperative blood loss in a Jehovah's Witness, treated with high-dose erythropoietin. (yeni pencere açar)

Schälte G, Janz H, Busse J, Jovanovic V, Rossaint R, Kuhlen R.

Kaynak‎: Br J Anaesth 2005;94(4):442-4.

İndeks‎: PubMed 15653706

DOI‎: 10.1093/bja/aei068

https://www.ncbi.nlm.nih.gov/pubmed/15653706 (yeni pencere açar)

Management of anemia in patients who decline blood transfusion. (yeni pencere açar)

Shander A, Goodnough LT

Kaynak‎: Am J Hematol 2018;93(9):1183-91.

İndeks‎: PubMed 30033541

DOI‎: 10.1002/ajh.25167

https://pubmed.ncbi.nlm.nih.gov/30033541/ (yeni pencere açar)

Erythropoiesis-stimulating agent administration and survival after severe traumatic brain injury: a prospective study. (yeni pencere açar)

Talving P, Lustenberger T, Inaba K, Lam L, Mohseni S, Chan L, Demetriades D.

Kaynak‎: Arch Surg 2012;147(3):251-5.

İndeks‎: PubMed 22430906

DOI‎: 10.1001/archsurg.2011.1838

https://www.ncbi.nlm.nih.gov/pubmed/22430906 (yeni pencere açar)

Intravenous iron following cardiac surgery does not increase the infection rate. (yeni pencere açar)

Torres S, Kuo YH, Morris K, Neibart R, Holtz JB, Davis JM.

Kaynak‎: Surg Infect (Larchmt) 2006;7(4):361-6.

İndeks‎: PubMed 16978079

DOI‎: 10.1089/sur.2006.7.361

https://www.ncbi.nlm.nih.gov/pubmed/16978079 (yeni pencere açar)

Erythropoietin improves long-term neurological outcome in acute ischemic stroke patients: a randomized, prospective, placebo-controlled clinical trial. (yeni pencere açar)

Tsai TH, Lu CH, Wallace CG, Chang WN, Chen SF, Huang CR, Tsai NW, Lan MY, Sung PH, Liu CF, Yip HK

Kaynak‎: Crit Care 2015;19:49.

İndeks‎: PubMed 25888250

DOI‎: 10.1186/s13054-015-0761-8

https://www.ncbi.nlm.nih.gov/pubmed/25888250 (yeni pencere açar)